Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07571239 · ClinicalTrials.gov registry record · NA
Altius Peripheral Nerve Stimulation in Amputees After TMR/RPNI
A NA study, sponsored by NYU Langone Health.
- Not yet
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT07571239 is a NA study that has not yet begun recruiting, run by NYU Langone Health. The registered enrollment target is 32 participants.
The verdict
NCT07571239, a NA study, has not yet begun recruiting, sponsored by NYU Langone Health.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
This is a single-center, prospective, within-subject study. This study seeks to enroll a total of 32 prospective subjects who will undergo surgical implantation of the FDA-approved Altius® system. Subjects will be followed longitudinally and will complete a series of patient-reported outcome measure questionnaires, a study intake questionnaire which assesses demographics, amputation and prosthesis history, and medical/medication history.
Interventions
- DEVICE Surgical Implantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2028-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07571239
The ClinicalTrials.gov registry entry for NCT07571239 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Surgical Implantation is the first listed.
NCT07571239 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07571239 about?
NCT07571239 is a clinical study titled "Altius Peripheral Nerve Stimulation in Amputees After TMR/RPNI". This is a single-center, prospective, within-subject study. This study seeks to enroll a total of 32 prospective subjects who will undergo surgical implantation of the FDA-approved Altius® system. Subjects will be followed longitudinally and will complete a series of patient-reported outcome measure...
What is the current status of trial NCT07571239?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2026-07-01. Estimated completion is 2028-07-01.
What interventions are being tested in trial NCT07571239?
The interventions under investigation include: Surgical Implantation (DEVICE).
Who is sponsoring clinical trial NCT07571239?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.